GENERIC AVAILABLE: No
PREPARATIONS: Capsules: 0.5 mg.
STORAGE: Fingolimod should be stored at room temperature, 15 C - 30 C (59 F - 86 F).
DOSING: The recommended dose is 0.5 mg orally once daily, with or without food. Doses higher than 0.5 mg cause more adverse reactions without providing additional benefit.
Vaccines may be less effective during and up to 2 months after discontinuation of fingolimod treatment. Live attenuated vaccines should not be administered during and for 2 months after fingolimod treatment because of the risk of infection.
PREGNANCY: Fingolimod has not been adequately studied in pregnant women.
NURSING MOTHERS: It is not known whether fingolimod is secreted in breast milk.
Medically reviewed by Eni Williams, PharmD
Reference: FDA Prescribing Information for Gilenya (fingolimod)
Quick GuideMultiple Sclerosis Pictures Slideshow: Causes, Symptoms and Treatment
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.